Gene · 54541
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis. | Front Microbiol | 2022 | 36147849 | PubTator, text mining | PubMed |
| Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy. | Medicina (Kaunas) | 2022 | 36143915 | PubTator, text mining | PubMed |
| Inflammation: Roles in Skeletal Muscle Atrophy. | Antioxidants (Basel) | 2022 | 36139760 | PubTator, text mining | PubMed |
| MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells. | Cancers (Basel) | 2022 | 36139642 | PubTator, text mining | PubMed |
| The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma. | Front Immunol | 2022 | 36131942 | PubTator, text mining | PubMed |
| CAV1 alleviated CaOx stones formation via suppressing autophagy-dependent ferroptosis. | PeerJ | 2022 | 36128191 | PubTator, text mining | PubMed |
| TXNIP inhibits the progression of osteosarcoma through DDIT4-mediated mTORC1 suppression. | Am J Cancer Res | 2022 | 36119812 | PubTator, text mining | PubMed |
| Muscle wasting in cancer: opportunities and challenges for exercise in clinical cancer trials. | JCSM Rapid Commun | 2022 | 36118249 | PubTator, text mining | PubMed |
| Conditional Deletion of HIF-2α in Mouse Nucleus Pulposus Reduces Fibrosis and Provides Mild and Transient Protection From Age-Dependent Structural Changes in Intervertebral Disc. | J Bone Miner Res | 2022 | 36117450 | PubTator, text mining | PubMed |
| TGF-β signaling in the tumor metabolic microenvironment and targeted therapies. | J Hematol Oncol | 2022 | 36115986 | PubTator, text mining | PubMed |
| An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature. | Front Oncol | 2022 | 36110952 | PubTator, text mining | PubMed |
| Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. | J Hematol Oncol | 2022 | 36104717 | PubTator, text mining | PubMed |
| Isoform-resolved mRNA profiling of ribosome load defines interplay of HIF and mTOR dysregulation in kidney cancer. | Nat Struct Mol Biol | 2022 | 36097292 | PubTator, text mining | PubMed |
| Autophagy regulated by the HIF/REDD1/mTORC1 signaling is progressively increased during erythroid differentiation under hypoxia. | Front Cell Dev Biol | 2022 | 36092719 | PubTator, text mining | PubMed |
Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response. | Front Pharmacol | 2022 | 36091754 | PubTator, text mining | PubMed |
| ATF3 as a potential diagnostic marker of early-stage osteoarthritis and its correlation with immune infiltration through bioinformatics analysis. | Bone Joint Res | 2022 | 36082523 | PubTator, text mining | PubMed |
| Lung Cell Toxicity of Metal-Containing Nanoparticles. | Nanomaterials (Basel) | 2022 | 36080081 | PubTator, text mining | PubMed |
| A Single-Cell Survey of Cellular Heterogeneity in Human Great Saphenous Veins. | Cells | 2022 | 36078120 | PubTator, text mining | PubMed |
| Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes. | Cancers (Basel) | 2022 | 36077821 | PubTator, text mining | PubMed |
| Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe? | Int J Mol Sci | 2022 | 36077083 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54541/papers?page=36